FDA di­rects spon­sors to keep in­formed con­sent in­fo con­cise, tai­lored to par­tic­i­pants

The FDA is aim­ing to make it eas­i­er for clin­i­cal tri­al par­tic­i­pants to un­der­stand in­formed con­sent, of­fer­ing tri­al spon­sors rec­om­men­da­tions for clar­i­fy­ing key in­for­ma­tion, as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER